An unambiguous message of support for carbon capture: a new ARC Centre of Excellence
The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.
Showing 201 - 220 of 1603 results
Common drug source of insights into formation of 'butterfly' crystals
Insights into the crystallisation process of twin crystals important for drug production.
ANSTO’s participation in 68th IAEA General Conference in Vienna advances international cooperation in the peaceful uses of nuclear science and technology
ANSTO joined the Australian delegation at the 68th General Conference of the International Atomic Energy Agency (IAEA) last month in Vienna, participating in a number of insightful side-events and fruitful bilateral partnership meetings.
NDF granted $2.8m NCRIS funding for expansion and development of capabilities
ANSTO recognises the contribution of staff for outstanding work, innovation, and excellence
ANSTO announces the recipients of the 2022 organisational awards
Expertise in characterising materials for lithium ion batteries
Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.
New radiocarbon calibration curves for a better dating method
The technique of using radiocarbon to establish the age of artefacts and other samples as well as to provide insights on climate, has just been updated with the publication of the new radiocarbon curves.
Strong collaborations bring success for ceramic engineering scientist
Dr Inna Karatchevtseva, who collaborates with DMTC, was among those identified by The Australian in its Research magazine as a national leader in her field of ceramic engineering
Eureka Prize win for Monash University and ANSTO
Recognition of research that developed a life-saving pharmaceutical milkshake using synchrotron techniques.
Licence application approved for Little Forest Legacy Site
License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Dire statistics for seabirds in latest plastics research
TSPO: Ancient gene ignites potential for drug development
Bipartisan support for national radioactive waste management facility
Instrument scientist featured in publication for PhD students
Two ANSTO nominees for On the Job competition
ANSTO provides groundwork for promising new nuclear medicine
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
US patent awarded for unique Australian mining technology
Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.